Stock events for Crescent Capital BDC, Inc. (CCAP)
Over the past six months, Crescent Capital BDC's stock has experienced several events and fluctuations. As of January 6, 2026, the share price was $14.35, a 23.75% decline from January 7, 2025. The 52-week range has been between $13.03 and $20.19. The Q3 2025 earnings report was released on November 12, 2025, after market close, and the company missed forecasts, with EPS of $0.46 and revenue of $41.35 million, leading to a share decline. The company declared a fourth-quarter base dividend of $0.42 per share in November 2025. In the past 90 days, the stock has seen one upgrade and one downgrade by analysts. As of January 9, 2026, the closing stock price was $14.49, with a year-to-date total return of 2.85%.
Demand Seasonality affecting Crescent Capital BDC, Inc.’s stock price
There is no explicit information indicating demand seasonality for Crescent Capital BDC's products and services. Its demand is likely more influenced by overall economic conditions, credit market dynamics, and the investment cycle of private companies rather than specific seasonal patterns.
Overview of Crescent Capital BDC, Inc.’s business
Crescent Capital BDC, Inc. is a specialty finance company operating as an externally managed, closed-end, non-diversified management investment company, regulated as a business development company. The company aims to maximize total return for stockholders through current income and capital appreciation by investing in the debt of private U.S. middle-market companies. It operates in the Financial Services sector, specializing in direct investing in middle-market companies, offering flexible financing solutions through secured and unsecured debt, as well as related equity securities, partnering with management teams across diverse industries to support growth initiatives, acquisitions, refinancings, and recapitalizations.
CCAP’s Geographic footprint
Crescent Capital BDC primarily focuses on originating and investing in the debt of private middle-market companies located principally in the United States. The broader Crescent Capital Group is headquartered in Los Angeles, with additional offices in New York, Boston, Chicago, and London.
CCAP Corporate Image Assessment
Crescent Capital BDC has a "Moderate Buy" consensus rating from Wall Street analysts, with an average rating score of 2.83 based on 6 analysts. MarketBeat indicates that Crescent Capital BDC scored higher than 66% of companies evaluated and ranked 509th out of 910 stocks in the finance sector. The company has a news sentiment score of -0.24. The disappointing Q3 2025 earnings led to some analyst caution, while the company's solid dividend coverage and history of meeting or exceeding its base dividend are seen as commendable. The company has been the subject of 4 research reports in the past 90 days.
Ownership
The ownership structure of Crescent Capital BDC stock includes institutional investors, insiders, public companies, and individual investors. Institutional investors own approximately 54.28% to 65.9% of the company's stock. Insiders own approximately 10.03% of the stock. Public companies and individual investors hold around 3.81% to 31.88% of the stock.
Ask Our Expert AI Analyst
Price Chart
$14.74